Trial · NCT05806918
Non-inferiority Study of ZK-A03 in Treatment of Herpes Zoster Before and After the Alteration of the Active Ingredient Manufacturer
NCT05806918, Phase 3, Unknown, Lee's Pharmaceutical Limited
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Non-inferiority Study of ZK-A03 in Treatment of Herpes Zoster Before and After the Alteration of the Active Ingredient Manufacturer. Trials, record NCT05806918. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05806918
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Non-inferiority Study of ZK-A03 in Treatment of Herpes Zoster Before and After the Alteration of the Active Ingredient Manufacturer
- NCT number
- NCT05806918
- Status
- Unknown
- Phases
- Phase 3
- Enrollment
- 368 participants, estimated
- Lead sponsor
- Lee's Pharmaceutical Limited
- Conditions
- Herpes Zoster
- Interventions
- Recombinant Human Interferon α-2b Gel (After the Alteration), Recombinant Human Interferon α-2b Gel (Before the Alteration)
- First posted
- 2023-04-10
- Last updated
- 2023-04-10
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Clinical cure rate at visit 4 (Day 7) | 7 Days | Clinical cure is defined as all blisters being dry and crustosus without erosion or ulceration. |
| Secondary | Clinical cure rate at visit 3 (Day 4), and visit 5 (Day 11) | 11 Days | Clinical cure is defined as all blisters being dry and crustosus without erosion or ulceration. |
| Secondary | Time to which new blisters stop appearing | 11 Days | The time from the first day of medication (D1) to the cessation of new blisters. |
| Secondary | The time to beginning of crusting. | 11 Days | The time from the first day of medication (D1) to the beginning of crusting. |
| Secondary | The time to which all blisters are crustosus. | 11 Days | The time from the first day of medication (D1) to the crustosus of all blisters. |
| Secondary | The pain improvement rate at visit 4 (Day 7) | 7 Days | Pain change of ≥1 from baseline is considered as pain improvement. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05806918
GET https://conductscience.org/api/trials/v1/NCT05806918/registered